In agreement with the above reports, our study found that CYP4B1 exerts protective effects through suppression of the STAT3 phosphorylation in both HF and LC, suggesting the therapeutic potential of targeting CYP4B1/STAT3 pathway for the management of these two conditions. This evidence concerns the gene CYP4B1 and hydrops fetalis.